Table 3.
RRR (95% CI) |
||||
---|---|---|---|---|
Model I |
Model II |
|||
Some pain | CWP | Some pain | CWP | |
Combination of LH and FSH levels | ||||
Normal/low LH and normal/low FSH | ||||
n = 1788 (56.14%) | Referent | Referent | Referent | Referent |
Normal/low LH and high FSH n = 342 (10.74%) | 0.95 (0.74 to 1.22) | 1.13 (0.72 to 1.76) | 0.99 (0.86 to 1.15) | 1.06 (0.76 to 1.47) |
High LH and normal/low FSH n = 338 (10.61%) | 1.16 (0.90 to 1.48) | 1.53 (1.01 to 2.43)⁎ | 1.14 (0.87 to 1.49) | 1.39 (0.85 to 2.30) |
High LH and high FSH n = 717 (22.51%) | 1.31 (1.07 to 1.59)⁎⁎ | 1.93 (1.39 to 2.69)⁎⁎⁎ | 1.29 (1.06 to 1.56)⁎ | 1.69 (1.36 to 2.10)⁎⁎⁎ |
Low corresponds to LH/FSH levels below the highest tertiles, high means in the highest tertiles.
Model I: adjusted for age. Model II: adjusted for age, smoking status, alcohol intake, body mass index, morbidities, Reuben’s Physical Performance Test walk time, depression, and centre. Base category for the outcome is no pain.
RRR = relative risk ratios, CI = confidence interval, LH = luteinising hormone, FSH = follicle-stimulating hormone, CWP = chronic widespread pain.
P < .05.
P < .01.
P < .001.